Acadia Pharmaceuticals Inc

Erste Asset Management GmbH ACAD

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/11/2026

Shares

133,700

Value ($000)

3,645

Weight

0.0%

2018 Q4 - 2025 Q4 (29 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/11/2026	3,645	0.0%	133,700	12/31/2025
2025 Q3	11/12/2025	2,850	0.0%	133,700	9/30/2025
2025 Q2	8/14/2025	3,988	0.0%	180,300	6/30/2025
2025 Q1	5/14/2025	4,136	0.1%	242,300	3/31/2025
2024 Q4	2/10/2025	4,107	0.1%	242,300	12/31/2024
2024 Q3	11/14/2024	3,802	0.0%	242,300	9/30/2024
2024 Q2	11/26/2024	3,966	0.1%	242,300	6/30/2024
2024 Q1	11/26/2024	4,410	0.1%	242,300	3/31/2024
2023 Q4	11/26/2024	4,654	0.1%	148,300	12/31/2023
2023 Q3	11/26/2024	2,855	0.0%	132,600	9/30/2023
2023 Q2	11/26/2024	2,174	0.0%	90,600	6/30/2023
2023 Q1	11/26/2024	1,694	0.0%	90,600	3/31/2023
2022 Q4	11/26/2024	1,445	0.0%	90,600	12/31/2022
2022 Q3	11/26/2024	1,462	0.0%	90,600	9/30/2022
2022 Q2	11/26/2024	1,288	0.0%	90,600	6/30/2022
2022 Q1	11/25/2024	2,212	0.0%	90,600	3/31/2022
2021 Q4	11/25/2024	2,432	0.0%	101,500	12/31/2021
2021 Q3	11/25/2024	1,721	0.0%	101,500	9/30/2021
2021 Q2	11/25/2024	2,449	0.0%	101,500	6/30/2021
2021 Q1	11/25/2024	2,610	0.1%	101,500	3/31/2021
2020 Q4	11/25/2024	5,459	0.2%	101,500	12/31/2020
2020 Q3	11/25/2024	4,950	0.2%	122,500	9/30/2020
2020 Q2	11/22/2024	5,009	0.2%	104,000	6/30/2020
2020 Q1	11/22/2024	4,752	0.3%	115,000	3/31/2020
2019 Q4	11/22/2024	2,515	0.1%	57,200	12/31/2019
2019 Q3	11/22/2024	1,699	0.1%	46,200	9/30/2019
2019 Q2	11/22/2024	1,221	0.1%	46,200	6/30/2019
2019 Q1	11/22/2024	1,231	0.1%	46,200	3/31/2019
2018 Q4	11/26/2024	714	0.0%	46,200	12/31/2018